ZA200301459B - Infusion of ciprofloxacin having reduced acid content and being stable in storage. - Google Patents
Infusion of ciprofloxacin having reduced acid content and being stable in storage.Info
- Publication number
- ZA200301459B ZA200301459B ZA200301459A ZA200301459A ZA200301459B ZA 200301459 B ZA200301459 B ZA 200301459B ZA 200301459 A ZA200301459 A ZA 200301459A ZA 200301459 A ZA200301459 A ZA 200301459A ZA 200301459 B ZA200301459 B ZA 200301459B
- Authority
- ZA
- South Africa
- Prior art keywords
- ciprofloxacin
- infusion
- stable
- storage
- acid content
- Prior art date
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 229960003405 ciprofloxacin Drugs 0.000 title 1
- 238000001802 infusion Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10048510A DE10048510A1 (de) | 2000-09-29 | 2000-09-29 | Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200301459B true ZA200301459B (en) | 2003-08-27 |
Family
ID=7658237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200301459A ZA200301459B (en) | 2000-09-29 | 2003-02-24 | Infusion of ciprofloxacin having reduced acid content and being stable in storage. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040082593A1 (pl) |
| EP (1) | EP1320368A1 (pl) |
| JP (1) | JP2004509921A (pl) |
| KR (1) | KR20030068541A (pl) |
| CN (1) | CN1466457A (pl) |
| AU (1) | AU2002214993A1 (pl) |
| BR (1) | BR0114293A (pl) |
| CA (1) | CA2420556A1 (pl) |
| DE (1) | DE10048510A1 (pl) |
| HU (1) | HUP0302256A2 (pl) |
| IL (1) | IL154509A0 (pl) |
| MX (1) | MXPA03002770A (pl) |
| NO (1) | NO20031411D0 (pl) |
| PL (1) | PL360597A1 (pl) |
| SK (1) | SK3322003A3 (pl) |
| WO (1) | WO2002026233A1 (pl) |
| ZA (1) | ZA200301459B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2591000B1 (en) | 2010-07-09 | 2017-05-17 | Janssen Vaccines & Prevention B.V. | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| ES2768651T3 (es) | 2013-04-25 | 2020-06-23 | Kyorin Seiyaku Kk | Composición farmacéutica sólida |
| CN105338981B (zh) | 2013-04-25 | 2017-10-13 | 杏林制药株式会社 | 固体药用组合物 |
| JP6018334B2 (ja) | 2014-10-23 | 2016-11-02 | 杏林製薬株式会社 | 固形医薬組成物 |
| JP6031217B1 (ja) | 2015-06-02 | 2016-11-24 | 杏林製薬株式会社 | 水性液剤 |
| EP3305294A4 (en) | 2015-06-02 | 2019-02-20 | Kyorin Pharmaceutical Co., Ltd. | AQUEOUS MEDICINE |
| WO2016195020A1 (ja) | 2015-06-02 | 2016-12-08 | 杏林製薬株式会社 | 水性液剤 |
| CN114767627B (zh) * | 2022-05-17 | 2024-05-31 | 广州南鑫药业有限公司 | 一种乳酸环丙沙星氯化钠注射液的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
| WO1990001933A1 (en) * | 1988-08-26 | 1990-03-08 | Alcon Laboratories, Inc. | Combination of quinolone antibiotics and steroids for topical ophthalmic use |
| DE10018781A1 (de) * | 2000-04-15 | 2001-10-25 | Fresenius Kabi De Gmbh | Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit |
| DE10018783A1 (de) * | 2000-04-15 | 2001-10-25 | Fresenius Kabi De Gmbh | Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt |
-
2000
- 2000-09-29 DE DE10048510A patent/DE10048510A1/de not_active Withdrawn
-
2001
- 2001-09-27 PL PL01360597A patent/PL360597A1/pl unknown
- 2001-09-27 BR BR0114293-3A patent/BR0114293A/pt not_active Application Discontinuation
- 2001-09-27 KR KR10-2003-7004311A patent/KR20030068541A/ko not_active Withdrawn
- 2001-09-27 SK SK332-2003A patent/SK3322003A3/sk unknown
- 2001-09-27 CN CNA018162606A patent/CN1466457A/zh active Pending
- 2001-09-27 JP JP2002530063A patent/JP2004509921A/ja active Pending
- 2001-09-27 AU AU2002214993A patent/AU2002214993A1/en not_active Abandoned
- 2001-09-27 WO PCT/EP2001/011189 patent/WO2002026233A1/de not_active Ceased
- 2001-09-27 MX MXPA03002770A patent/MXPA03002770A/es unknown
- 2001-09-27 IL IL15450901A patent/IL154509A0/xx unknown
- 2001-09-27 US US10/381,839 patent/US20040082593A1/en not_active Abandoned
- 2001-09-27 CA CA002420556A patent/CA2420556A1/en not_active Abandoned
- 2001-09-27 HU HU0302256A patent/HUP0302256A2/hu unknown
- 2001-09-27 EP EP01983507A patent/EP1320368A1/de not_active Withdrawn
-
2003
- 2003-02-24 ZA ZA200301459A patent/ZA200301459B/xx unknown
- 2003-03-27 NO NO20031411A patent/NO20031411D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0302256A2 (hu) | 2003-11-28 |
| BR0114293A (pt) | 2003-07-29 |
| NO20031411D0 (no) | 2003-03-27 |
| DE10048510A1 (de) | 2002-05-16 |
| AU2002214993A1 (en) | 2002-04-08 |
| US20040082593A1 (en) | 2004-04-29 |
| CN1466457A (zh) | 2004-01-07 |
| WO2002026233A1 (de) | 2002-04-04 |
| MXPA03002770A (es) | 2004-12-13 |
| PL360597A1 (pl) | 2004-09-20 |
| SK3322003A3 (en) | 2003-07-01 |
| WO2002026233B1 (de) | 2002-07-04 |
| KR20030068541A (ko) | 2003-08-21 |
| CA2420556A1 (en) | 2003-02-25 |
| EP1320368A1 (de) | 2003-06-25 |
| JP2004509921A (ja) | 2004-04-02 |
| IL154509A0 (en) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002002093A3 (en) | Combination containing an antifolate and methylmalonic acid lowering agent | |
| WO2000061192A3 (en) | Methods and compositions for the treatment of pancreatitis | |
| MXPA02005797A (es) | Metodos y dispositivos electroquimicos para su uso en la determinacion de concentraciones de analitos con hematocrito corregido. | |
| AU2002332580A1 (en) | Cell storage and delivery system | |
| WO2004052401A3 (en) | Compositions and methods of delivery of pharmacological agents | |
| MX295630B (es) | Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos. | |
| IL144508A0 (en) | Compositions and methods for use in targeting vascular destruction | |
| AU2002340415A1 (en) | Compositions containing enzymes stabilized with certain osmo-protectants and methods for using such compositions in personal care | |
| MXPA03005923A (es) | Derivados de glupopiranosiloxipirazol y su uso en medicinas. | |
| AU2002254942A1 (en) | Paracetamol solutions which are stable in storage and ready for infusion | |
| AU4303600A (en) | Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate | |
| AU2001273941A1 (en) | Ciprofloxacin infusion solutions having a good storage stability | |
| WO2002032397A8 (en) | Electroprocessing in drug delivery and cell encapsulation | |
| PL360597A1 (pl) | Trwałe w czasie przechowywania roztwory cyprofloksacyny do infuzji, o zmniejszonej zawartości kwasu | |
| AU2001226651A1 (en) | Porphyrin containing lactic acid bacterial cells and use thereof | |
| ZA200004406B (en) | Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal. | |
| AU2001282317A1 (en) | Capture, storage and retrieval of markup elements | |
| AU1531501A (en) | Hydrate storage and transportation | |
| AU2002347455A1 (en) | Improvements in and relating to content delivery | |
| HUP0301119A3 (en) | Biologically active agent and drug | |
| AU2001260198A1 (en) | Ciprofloxacin infusion solutions with improved storage life | |
| AU2003256741A8 (en) | Ketocampholenic acid derivatives and their use in fragrance and flavour applications | |
| AU2001286110A1 (en) | Freight handling and storage | |
| AU4851601A (en) | Storage and transport vessel | |
| AU2001269106A1 (en) | Novel alpha expressed in heart and testis |